Skip to main content

Table 2 Comparison of epidemiological, demographic, immunologic and virological characteristics between Blastocystis- carrier (N = 39) and Blastocystis-free (N = 117) patients. Significant results were marked with *

From: Molecular characterization of Blastocystis subtypes in HIV-positive patients and evaluation of risk factors for colonization

 

Blastocystis-carriers N (%)

Blastocystis-free N (%)

p-value

Gender, male

33 (82.0%)

84 (72.6%)

0.289

Age, years (mean ± SD)

44.71 ± 11.33

47.05 ± 12.37

0.06

Foreign origin

15 (38.46%)

25 (21.36%)

0.138

MSM

19 (48.71%)

31 (26.49%)

0.037*

Domestic animals

18 (46.15%)

56 (47.86%)

0.721

Travels

20 (51.28%)

47 (40.17%)

0.296

CD4 count, cells/ml, mean ± SD

637.43 ± 263.32

660.90 ± 414.35

0.823

CD4 count > 500 cells/ml

28 (71.79%)

69 (58.97%)

0.484

CD4 count 200–500 cells/ml

8 (20.51%)

33 (28.20%)

CD4 count < 200 cells/ml

3 (7.69%)

15 (12.82%)

HIV-RNA (< 37 copies/ml)

32 (82.05%)

80 (68.37%)

0.257

Naïve subjects

5 (12.82%)

18 (15.38%)

0.765

2NRTI + NNRTI

9 (23.07%)

26 (22.22%)

2NRTI + IP/r

7 (17.94%)

27 (23.07%)

2NRTI + INI

12 (30.76%)

24 (20.51%)

Dual therapy

6 (15.38%)

22 (18.80%)